Market Cap
775178496.00
ORIC
ORIC Pharmaceuticals, Inc.
Exchange: nyse
Multiples
- P/E: -6.47
- P/BV: 2.83
- P/TBV: 3.46
Description:
ORIC refers to Oric Pharmaceuticals Inc., a biopharmaceutical company listed on the New York Stock Exchange (NYSE). The company focuses on developing therapies for patients with cancer, leveraging its expertise in precision medicine and targeted oncology treatments. ORIC's pipeline includes investigational drugs aimed at addressing unmet medical needs in various forms of cancer, positioning it as an emerging player in the oncology sector. Investors interested in biotech and pharmaceuticals might find ORIC an intriguing option due to its specialized focus and potential for innovation in cancer treatment.
Data:
Yields:
